The Scientist

» cancer and microbiology

Most Recent

image: Virus Versus Bacteria

Virus Versus Bacteria

By | April 17, 2013

A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.

1 Comment

image: Week in Review: April 8-12

Week in Review: April 8-12

By | April 12, 2013

Hot topics from the AACR meeting; the ongoing debate about pesticides’ effects on bees; a treasure trove of baby dinos; conservation on social media

0 Comments

image: AACR Talk

AACR Talk

By | April 11, 2013

Some notable quotes from this week’s meeting on cancer research

0 Comments

image: Week in Review: April 1-5

Week in Review: April 1-5

By | April 5, 2013

Living fossils not so fossilized; Canadian gov’t threatens scientists’ freedom to speak and publish; gene therapy for sensory disorders; an unusual theory of cancer; clues for an HIV vaccine

0 Comments

image: Cancer Growth Curtailed

Cancer Growth Curtailed

By | April 4, 2013

Researchers develop two small molecules that slow the growth of human cancer cells.

0 Comments

image: Q&A: The Cancer Tradeoff

Q&A: The Cancer Tradeoff

By | April 3, 2013

Physicist-turned-oncologist Robert Austin argues that cancer is a natural consequence of our rapid evolution.

26 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Making Cancer More Transparent

Making Cancer More Transparent

By | April 1, 2013

A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.

3 Comments

image: Sarkis Mazmanian: Microbe Machinist

Sarkis Mazmanian: Microbe Machinist

By | April 1, 2013

Professor, Division of Biology, California Institute of Technology. Age: 40

0 Comments

image: Up, Up, and Array

Up, Up, and Array

By | April 1, 2013

By scrutinizing gene expression profiles instead of individual oncogenes, Todd Golub launched a powerful platform for diagnosing, classifying, and treating cancer.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech